Drug Policy Archives - Page 4 of 55

Psychedelics Policy Newsletter: Reforms for Congress, data for rescheduling, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — April 2025

Commentary by Gregory Ferenstein

Oregon House Bill 2387 would improve psilocybin services

Testimony by Leonard Gilroy, Geoffrey Lawrence and Gregory Ferenstein

Maine Legislative Document 1034 would decriminalize personal-use psilocybin

Testimony by Madison Carlino

Nevada Assembly Bill 307 would change how cannabis is taxed

Testimony by Geoffrey Lawrence

Ohio Senate Bill 86 would needlessly restrict the hemp industry

Testimony by Michelle Minton

Nevada Assembly Bill 378 could help patients access psychedelic therapies

Testimony by Madison Carlino

Optimal framework for the state regulation of hemp cannabinoids

Backgrounder by Michelle Minton and Geoffrey Lawrence

Exploring new data on the safety of psychedelics

Commentary by Gregory Ferenstein

More Drug Policy

Prev
1
2
3
4
5
6
7
...
55
Next